COSMETICS APPLICATION

04.C08

Controlled Release
engineered with chitosan.

Tunable films, particles and gels that can extend or sequence release of selected cosmetic ingredients.

Precision liquid formulation prepared for controlled-release testing
COSMETICS · CONTROLLED RELEASE
FORMULATION + SAMPLE PROGRAMCOSMETICS

01 · THE CUSTOMER PROBLEM

Formulators need selected actives or fragrances to remain available longer instead of delivering all at once or degrading in the package.

Chitosan films, particles and gels provide multiple release-control levers through MW, DDA, crosslinking and matrix design.

Tunable films, particles and gels that can extend or sequence release of selected cosmetic ingredients.

02 · RECOMMENDED STARTING POINT

Start with the material designed for the decision.

MYKITO PLATFORMBioFoundry
RECOMMENDED SAMPLEA controlled-release feasibility sample built around one priority active.

Molecular weight, DDA, crosslinking and blend composition provide multiple tools for changing diffusion, erosion and active release.

01

Without the shell

Controlled fungal sourcing supports a traceable, non-animal supply strategy.

02

Specification engineered

MW, DDA, purity, charge density and format are selected around the target result.

03

Application ready

Powder is only the starting point; Mykito also develops films, fibers, gels, coatings and formulations.

04

One technical partner

Material selection, formulation support and the validation plan are connected from the first sample.

03 · PERFORMANCE TARGETS

Build toward outcomes a buyer can measure.

01

Sustained active delivery

Sustained active delivery can be developed by matching the chitosan specification, dose and application-ready format to the finished controlled release system.

02

Triggered release concepts

Triggered release concepts can be developed by matching the chitosan specification, dose and application-ready format to the finished controlled release system.

03

Longer surface residence

Longer surface residence can be developed by matching the chitosan specification, dose and application-ready format to the finished controlled release system.

04 · GO / NO-GO CRITERIA

Define the evidence before testing begins.

The first program is designed around three decision-making outputs—not an open-ended material trial.

01

Loading and dose uniformity

02

Release kinetics and stability

03

Finished-form sensory and efficacy

Release kineticsDose uniformityStabilitypH responseFinished-form testing

05 · FROM SAMPLE TO DECISION

A practical application program,
not a bag of powder.

01

Define

Agree on the function, baseline, constraints and measurable success criteria.

02

Screen

Select the MW, DDA, purity, dose and physical format that fit the application.

03

Validate

Test the winning system in the finished formulation, device, process or use environment.

AVAILABLE FORMATS
NanoparticlesHydrogelsFilms + coatings

Recommended first request: A controlled-release feasibility sample built around one priority active.

Start the Sample Brief

06 · WHY CHITOSAN

Deposition + hydrated film formation

Cationic charge and interfacial adhesion can increase surface residence, while continuous polymer films support moisture management and active carrying.

FORMULATION WINDOW

There is no universal concentration. Grade and dose are screened against pH, interacting ingredients, process conditions and the target performance profile.

QUALIFICATION

Appearance, sensory, stability, preservation and performance are validated in the finished cosmetic formula.

START A FORMULATION PROGRAM

Move from material potential
to a defined program.

Tell us what performance, purity and format your application needs. We will help identify the right Mykito platform and a practical next step.